Iowa
Alzheimer's disease clinical trials in Iowa
3 Alzheimer's disease studies are recruiting participants at sites in 2 cities across Iowa as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Iowa city with a recruiting study
Iowa City (2), Waterloo (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Recently updated studies in Iowa
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Phase 3
- Ages 55 and older
- All sexes
- Sponsor
- Eli Lilly and Company
- Recruiting in
- Waterloo
- Registry record
- NCT07602582 · updated
Disease Modifying Potential of 5mg of Melatonin on Cognition and Brain Health in Aging
- No phase
- Ages 56 to 85
- All sexes
- Sponsor
- Natalie Denburg
- Recruiting in
- Iowa City
- Registry record
- NCT03954899 · updated
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
- No phase
- Ages 18 to 100
- All sexes
- Sponsor
- University of Iowa
- Recruiting in
- Iowa City
- Registry record
- NCT07032350 · updated
Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in Iowa on ClinicalTrials.gov.
Ask about studies in Iowa
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections